Arxis, Cigna and Vylor among US analyst rating and price target changes
ARXS•Analysts raised Arxis to outperform from sector perform and lifted its price target to $60 from $50. Piper Sandler raised Cigna’s target to $370 from $346, while RBC initiated Vylor coverage with an outperform rating and an $85 target.
1. Highlighted analyst moves
RBC raised Arxis to outperform from sector perform and increased its price target to $60 from $50. Piper Sandler raised its Cigna price target to $370 from $346. RBC initiated coverage of Vylor with an outperform rating and an $85 price target.
2. Other research changes
The roundup also included rating and price-target changes for companies including Nike, Northrop Grumman, Foghorn Therapeutics, and Palo Alto Networks. Nike received four price-target cuts, while RBC cut Northrop Grumman to sector perform from outperform and lowered its target to $525 from $640.
